The labelling and imaging of tumor cells were investigated via arginine-glycine-aspartic acidcysteine（RGDC） peptide-labelled quantum dots（QDs）. The results show that RGDC modified QDs can label SMMC-7721 tumor cel...The labelling and imaging of tumor cells were investigated via arginine-glycine-aspartic acidcysteine（RGDC） peptide-labelled quantum dots（QDs）. The results show that RGDC modified QDs can label SMMC-7721 tumor cells and adhere to cellular membrane. In constrast, the unmodified QDs are mainly dispersed around the cell. We also found that the RGDC-QDs can penetrate into the cell at 2 h of incubation. After 6 h of incubation, RGDC-QDs can accumulate in a unique intracellular region.展开更多
基金Supported by the National Natural Science Foundation of China(Nos.30970719, 21043002)the Social Development Project of Science and Technology Department of Jilin Province, China(Nos.20106031, 20090133)+1 种基金the Project of Science and Technology Department of Changchun City, China(No.09SF02)the Fundamental Research Funds of Jilin University, China (No.200903098)
文摘The labelling and imaging of tumor cells were investigated via arginine-glycine-aspartic acidcysteine（RGDC） peptide-labelled quantum dots（QDs）. The results show that RGDC modified QDs can label SMMC-7721 tumor cells and adhere to cellular membrane. In constrast, the unmodified QDs are mainly dispersed around the cell. We also found that the RGDC-QDs can penetrate into the cell at 2 h of incubation. After 6 h of incubation, RGDC-QDs can accumulate in a unique intracellular region.
